Market Overview

The Global Cardiac Marker Analyzer Market was valued at USD 915.7 million in 2023 and is expected to reach USD 1,342.6 million by 2031 while growing at a CAGR of 4.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cardiac marker analyzer market growth. Cardiac marker analyzers, also known as cardiac reader systems, offer high-throughput point-of-care solutions for diagnosing myocardial infarction and other cardiac-related diseases. They measure levels of STAT, cardiac troponin, CKM, CKB, myoglobin, and/or D-dimer in as little as 14 minutes, equivalent to 36 tests per hour. These analyzers utilize immunochromatographic assays to perform these tests efficiently.

The ongoing advancements in technology, including enhancements in assay sensitivity, specificity, and automation capabilities, significantly improve the performance and efficiency of cardiac marker analyzers. Additionally, the increasing adoption of point-of-care testing drives market growth. However, cost constraints and competition from alternative testing methods pose challenges to further market expansion.

Furthermore, the global cardiac marker analyzer industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Analysis

The Global Cardiac Marker Analyzer Market is segmented among Immuno-fluorescence Analyzers (IFAs), Magnetic Immuno-Chromatographic Assay (MICA) Analyzers, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Analyzers, and Enzyme Immunoassay (EIA) Analyzers, based on Product. In 2023, Chemiluminescence Immunoassay (CLIA) Analyzers accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End-Users Analysis

The Global Cardiac Marker Analyzer Market is segmented among Hospitals, Diagnostic Centers, and Academic and Research institutes, based on End-Users. In 2023, Diagnostic Centers accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Cardiac Marker Analyzer Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are F. Hoffmann-La Roche Ltd., Quidel Corporation, CardioGenics Holdings Inc., Abbott Laboratories, PHC Holdings Corporation (LSI Medience Corporation), Thermo Fisher Scientific (Fisher Scientific), Siemens Healthineers AG, Danaher (Beckman Coulter Inc.), Trinity Biotech PLC, and Boditech Med Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Cardiac Marker Analyzer Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Cardiac Marker Analyzer Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Cardiac Marker Analyzer Market Segmentation, By Product

• Global Cardiac Marker Analyzer Market Share Analysis, By Product

• Global Cardiac Marker Analyzer Market Growth Analysis, By Product

• Global Cardiac Marker Analyzer Market Trends, By Product

o Immuno-fluorescence Analyzers (IFAs)

o Magnetic Immuno-Chromatographic Assay (MICA) Analyzers

o Chemiluminescence Immunoassay (CLIA) Analyzers

o Radioimmunoassay (RIA) Analyzers

o Enzyme Immunoassay (EIA) Analyzers

6. Global Cardiac Marker Analyzer Market Segmentation, By End-Users

• Global Cardiac Marker Analyzer Market Share Analysis, By End-Users

• Global Cardiac Marker Analyzer Market Growth Analysis, By End-Users

• Global Cardiac Marker Analyzer Market Trends, By End-Users

o Hospitals

o Diagnostic Centers

o Academic and Research institutes

7. Global Cardiac Marker Analyzer Market Segmentation, By Region

• Global Cardiac Marker Analyzer Market Share Analysis, By Region

• Global Cardiac Marker Analyzer Market Growth Analysis, By Region

• Global Cardiac Marker Analyzer Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• F. Hoffmann-La Roche Ltd.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Quidel Corporation

• CardioGenics Holdings Inc.

• Abbott Laboratories

• PHC Holdings Corporation (LSI Medience Corporation)

• Thermo Fisher Scientific (Fisher Scientific)

• Siemens Healthineers AG

• Danaher (Beckman Coulter Inc.)

• Trinity Biotech PLC

• Boditech Med Inc.

*Similar analysis will be provided for each company listed above.